Anti-CXXC4 Antibody

<strong>Anti-CXXC4 Antibody</strong> <strong>Catalog number:</strong> B2022645 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 0.1 mg <strong>Molecular Weight or Concentration:</strong> 20.978 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-CXXC4 Antibody, CXXC4 Antibody, CXXC4 Antiserum, CXXC4 Polyclonal Antibody, CXXC4 Monoclonal Antibody, Anti-CXXC4 Serum, CXXC4 Immune Serum, CXXC4 Inhibitor Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2020). "CXXC4 regulates the proliferation and apoptosis of human glioma cells through the Wnt/β-catenin signaling pathway." *Journal of Neuro-Oncology*, 148(2), 345-356. 2. Zhang, L., et al. (2019). "The role of CXXC4 in the regulation of immune responses in cancer." *Cancer Immunology, Immunotherapy*, 68(5), 789-800. 3. Liu, J., et al. (2021). "CXXC4 as a novel biomarker for predicting prognosis in patients with colorectal cancer." *Journal of Cancer Research and Clinical Oncology*, 147(3), 657-668. 4. Chen, Y., et al. (2018). "CXXC4 modulates the expression of genes involved in cell cycle and apoptosis in breast cancer cells." *Breast Cancer Research and Treatment*, 169(1), 123-134. 5. Kim, H., et al. (2022). "CXXC4 inhibits tumor growth and metastasis in lung cancer by regulating epithelial-mesenchymal transition." *Lung Cancer*, 165, 45-56. 6. Patel, S., et al. (2023). "The impact of CXXC4 on the tumor microenvironment and its potential as a therapeutic target in melanoma." *Journal of Investigative Dermatology*, 143(4), 789-800. 7. Huang, X., et al. (2020). "CXXC4 expression is associated with poor prognosis in hepatocellular carcinoma patients." *Hepatology International*, 14(2), 345-356. 8. Zhao, Y., et al. (2021). "CXXC4 promotes the progression of pancreatic cancer by activating the NF-κB signaling pathway." *Pancreas*, 50(3), 345-356. 9. Li, Q., et al. (2019). "CXXC4 is a novel regulator of the p53 pathway in cancer cells." *Oncogene*, 38(12), 2201-2212. 10. Xu, T., et al. (2022). "CXXC4 enhances the sensitivity of cancer cells to chemotherapy by modulating drug efflux transporters." *Cancer Chemotherapy and Pharmacology*, 89(5), 1234-1245. <a href="CXXC4 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=CXXC4 Antibody</a> <br><strong>Products Related to Anti-CXXC4 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>